Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAM Enzymatic Assay from US Patent US11591338: "Pyrrolotriazine compounds as TAM inhibitors"
Assay data:142 Active, 144 Activity ≤ 1 µM, 144 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000542a TYRO3
Assay data:1 Tested
SummaryRelated BioAssays by Target
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000300bCl TYRO3
Affinity Biochemical interaction (HTRF assay) EUB0000147b TYRO3
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Affinity Biochemical interaction (Enzyme activity assay) EUB0000624a TYRO3
Affinity Phenotypic Cellular interaction (CellTiter-Glo assay (Promega, proliferation in H1703 cell line)) EUB0000147b TYRO3
Assay data:1 Active, 1 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Affinity Phenotypic Cellular interaction (MTT assay (Promega; inhibition of cell proliferation in Met-driven H1993 cells)) EUB0000624a TYRO3
Inhibition of TYRO3 (unknown origin)
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human RSE (451 to end residues) assessed as residual activity at 1 uM using KVEKIGEGTYGVVYK as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting method relative to control
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of Tyro3 (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate incubated for 180 mins in presence of ATP by microfluidic capillary electrophoresis analysis
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
TYRO3 DiscoveRx kinase panel
Rse(h) Kinase panel
Inhibition of TYRO3 (unknown origin) at 1 uM
Inhibition of human RSE in presence of ATP by radiometric assay
Enzyme Assay from US Patent US11247990: "Bicyclic fused pyridine compounds as inhibitors of TAM kinases"
Assay data:458 Active, 508 Activity ≤ 1 µM, 508 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
TAM Enzymatic Assay from US Patent US11241438: "Formulations of an AXL/MER inhibitor"
TAM Kinase Assay from US Patent US11136326: "Pyrrolopyrimidine derivatives as TAM inhibitors"
Assay data:82 Active, 54 Activity ≤ 1 µM, 90 Tested
Enzymatic Assay from US Patent US11104682: "Salts of TAM inhibitors"
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Enzyme Assay from US Patent US11104676: "Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases"
Assay data:186 Active, 6 Activity ≤ 1 nM, 148 Activity ≤ 1 µM, 188 Tested
Verification on Inhibitory Activities of TAM Receptor Inhibiting Compounds on Tyro 3, Axl, and Mer from US Patent US11053225: "Pyrimidine derivative compound, optical isomer thereof, or pharmaceutically acceptable salt thereof, and composition for preventing or treating Tyro 3 related disease comprising same as active ingredient"
Assay data:133 Active, 43 Activity ≤ 1 nM, 119 Activity ≤ 1 µM, 138 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on